Clinical and Applied Thrombosis/Hemostasis (Oct 2022)

Fibrinolytic Changes in Women with Preeclampsia

  • Anne Cathrine Godtfredsen MD,
  • Johannes Jakobsen Sidelmann PhD,
  • Britta Blume Dolleris MD,
  • Jan Stener Jørgensen MD, PhD,
  • Emma Kathrine Jungjohan Johansen,
  • Melissa Fernard Bøg Pedersen,
  • Yaseelan Palarasah PhD,
  • Jørgen Brodersen Gram MD, D. Sc

DOI
https://doi.org/10.1177/10760296221126172
Journal volume & issue
Vol. 28

Abstract

Read online

Objectives Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. Aim To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. Design and Methods 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed. Results Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p = 0.0004 p = 0.04, p = 0.03, p < 0.0001 respectively. Conclusion This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy.